Editorial: Bridging the gap: an interdisciplinary perspective on ketamine in psychiatric disorders
Glenn Hartelius, Sherry-Anne Muscat, Lucie Bartova
Frontiers in Psychiatry August 14, 2023 DOI: 10.3389/fpsyt.2023.1246891 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Esketamine Ketamine |
| Citations | 4 |
Abstract
EDITORIAL article Front. Psychiatry, 14 August 2023Sec. Psychopharmacology Volume 14 - 2023 | https://doi.org/10.3389/fpsyt.2023.1246891
Citations in the library
Cited by 2
Cites 13
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial American Journal of Psychiatry August 28, 2013
- The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis American Journal of Psychiatry October 3, 2017
- Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. American Journal of Psychiatry March 29, 2019
- Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy Journal of Psychoactive Drugs March 15, 2019
- Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study Neuropsychopharmacology May 12, 2023
and 8 more in the library